ZOE.F Zoetis Inc. R
Healthcare · Drug Manufacturers - Specialty & Generic
61.76
-1.37%
À propos de l'entreprise
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Plage 52 semaines
Analyse approfondie du dividende
Zoetis Inc., a Healthcare sector company specializing in Drug Manufacturers - Specialty & Generic, currently offers a dividend yield of 2.95% in EUR. This yield is significantly above its 5-year average of 0.87% and its 5-year high of 1.35%. Valuation analysis suggests the stock is currently undervalued according to Yield Theory, though its fair value calculation indicates the price is 4.6% above fair value, suggesting a "fair" margin of safety. Momentum and value scores are not available, nor is an overall rating score.
Historique des dividendes
Zoetis has a history of consistent dividend increases, maintaining a streak of 12 consecutive years. The company has demonstrated strong dividend growth with a 3-year compound annual growth rate (CAGR) of 15.44% and a 5-year CAGR of 20.11%. Annual dividends per share in EUR have increased steadily: 0.2539 in 2014, 0.3703 in 2017, 0.5783 in 2019, 0.8816 in 2021, 1.1461 in 2022, 1.3224 in 2023, and projected to 1.7632 in 2025. It is recognized as a Dividend Contender.
Sécurité du dividende
The dividend appears well-covered with a payout ratio of 33.77% based on earnings per share. In terms of leverage, Zoetis has a debt-to-equity ratio of 293.996%.
Quantic · Gratuit
Lis la suite de la sécurité du dividende
Avec les risques clés et ce qu'il faut surveiller ensuite. Gratuit, sans carte.
Généré par IA à partir des données de dividendes de Quantic · Mis à jour le 29 Sept 2026 · À titre informatif uniquement — pas un conseil financier.
Affiché en anglais — une traduction arrive.
Historique des prix
Profil de dividende
Fourchette de rendement Le rendement du dividende actuel d'une action comparé à sa propre fourchette des cinq dernières années — le bas, la moyenne et le haut. Près du haut, l'action paraît relativement bon marché pour le revenu qu'elle verse ; près du bas, relativement chère. C'est l'image derrière la Théorie du Rendement du Dividende. En savoir plus → (5 ans)
Calendrier des versements
Historique des dividendes
Dividende par action par année
Dette et levier
Derniers chiffres du bilan publiés.
Suivie par 1 investisseur
Figure dans ces listes
ZOE.F remplit les critères de ces classements de dividendes.
Nouveau dans l'investissement en dividendes ?
À titre informatif uniquement — pas un conseil financier.
Quantic · Gratuit
Suivez ZOE.F et tout votre portefeuille
Rendement réel, sécurité du dividende, revenu net d'impôt et votre chemin vers la liberté — gratuit, sans connexion au courtier.
Besoin de plus ? Pro ajoute des portefeuilles, le suivi des revenus d'options et plus d'IA. Voir Pro →